Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika CofiledCriticalMeiji Seika Co
Priority to KR7400139ApriorityCriticalpatent/KR790000302B1/en
Application grantedgrantedCritical
Publication of KR790000302B1publicationCriticalpatent/KR790000302B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esters (I; R=lower alkyl) of D-glucalo-1, 5-lactam derivs. were prepd. by esterification of inorg. salts as Na, K, Ca, Ba, Cu, Ag or salts of org. amine as triethanolamine of D-glucalo-1, 5-lactam with RX(R=lower alkyl, X=I, Br, Cl) insolvents as dimethylformaldehyde, dimethylsuphoxide, dimethylacetamide. I had -glucuronidaseinhibiting activity, useful for treating and preventing all diseases in which -glucuronidase activity increases.
KR7400139A1974-01-041974-01-04Process for d-glucalo-1,5-lactam derivative
KR790000302B1
(en)
Derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid, especially for use as hypolipidemic agents, processes for their preparation, pharmaceutical compositions comprising them, tetrahydropyran-2,3,5-triones useful in the preparation of the said derivatives and a process for preparing these tetrahydropyran-2,3,5-triones.
Process for producing 2-carbalkoxyamino-5-bracket-6-bracket closed-phenyl-sulphonyloxy-benzimidazole derivatives and anthelmintic compositions containing them as active agents